Supporting Patient Continuity with Inhixa® – Visit Techdow at Stand B84

Techdow Pharma England Limited is committed to delivering high-quality, cost-effective solutions for the prevention and treatment of venous thromboembolism (VTE), including deep vein thrombosis (DVT). As specialists in Low Molecular Weight Heparin (LMWH), our focus is on ensuring consistent patient outcomes through reliable supply and clinical excellence.

As part of the Hepalink Group, Techdow maintains full control over its supply chain, from raw material sourcing to final product delivery. This integrated approach ensures continuity, reliability, and confidence in every dose of Inhixa®.
Join us at Stand B84 to learn more about Inhixa® and take advantage of our team being on hand to answer any queries or questions.  Meet the Techdow team in person to explore how Inhixa® can support your pharmacy’s commitment to patient continuity and clinical excellence.

Supporting Continuity of Care
With multiple enoxaparin brands available in the UK, differences in colour coding, syringe graduations, and administration techniques can lead to confusion. It is important that patients receive the brand they were trained to use in hospital.

Stock Inhixa® today and ensure your patients receive the treatment they recognise. Available to order through AAH and Phoenix.

Contact Us
Have questions before the show? Reach out to our team at corporate@techdow.co.uk or call 01483 928 995.

For Abbreviated Prescribing Information, please visit https://www.techdow-pharma.co.uk/inhixa.html or scan the below QR code.

Adverse Event Reporting
Adverse events should be reported via the Yellow Card Scheme and to Techdow directly at 01483 928 995 or PV@techdow.co.uk.